Literature DB >> 16492766

Cocaine-induced dendritic spine formation in D1 and D2 dopamine receptor-containing medium spiny neurons in nucleus accumbens.

Ko-Woon Lee1, Yong Kim, Amie M Kim, Kathryn Helmin, Angus C Nairn, Paul Greengard.   

Abstract

Psychostimulant-induced alteration of dendritic spines on dopaminoceptive neurons in nucleus accumbens (NAcc) has been hypothesized as an adaptive neuronal response that is linked to long-lasting addictive behaviors. NAcc is largely composed of two distinct subpopulations of medium-sized spiny neurons expressing high levels of either dopamine D1 or D2 receptors. In the present study, we analyzed dendritic spine density after chronic cocaine treatment in distinct D1 or D2 receptor-containing medium-sized spiny neurons in NAcc. These studies made use of transgenic mice that expressed EGFP under the control of either the D1 or D2 receptor promoter (Drd1-EGFP or Drd2-EGFP). After 28 days of cocaine treatment and 2 days of withdrawal, spine density increased in both Drd1-EGFP- and Drd2-EGFP-positive neurons. However, the increase in spine density was maintained only in Drd1-EGFP-positive neurons 30 days after drug withdrawal. Notably, increased DeltaFosB expression also was observed in Drd1-EGFP- and Drd2-EGFP-positive neurons after 2 days of drug withdrawal but only in Drd1-EGFP-positive neurons after 30 days of drug withdrawal. These results suggest that the increased spine density observed after chronic cocaine treatment is stable only in D1-receptor-containing neurons and that DeltaFosB expression is associated with the formation and/or the maintenance of dendritic spines in D1 as well as D2 receptor-containing neurons in NAcc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16492766      PMCID: PMC1413917          DOI: 10.1073/pnas.0511244103

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  63 in total

Review 1.  Molecular basis of long-term plasticity underlying addiction.

Authors:  E J Nestler
Journal:  Nat Rev Neurosci       Date:  2001-02       Impact factor: 34.870

2.  Studies on the distinction between uptake inhibition and release of (3H)dopamine in rat brain tissue slices.

Authors:  R E Heikkila; H Orlansky; G Cohen
Journal:  Biochem Pharmacol       Date:  1975-04-15       Impact factor: 5.858

3.  The dopamine D-1 receptor antagonist SCH 23390 injected into the dorsolateral bed nucleus of the stria terminalis decreased cocaine reinforcement in the rat.

Authors:  M P Epping-Jordan; A Markou; G F Koob
Journal:  Brain Res       Date:  1998-02-16       Impact factor: 3.252

4.  Effects of chronic exposure to cocaine are regulated by the neuronal protein Cdk5.

Authors:  J A Bibb; J Chen; J R Taylor; P Svenningsson; A Nishi; G L Snyder; Z Yan; Z K Sagawa; C C Ouimet; A C Nairn; E J Nestler; P Greengard
Journal:  Nature       Date:  2001-03-15       Impact factor: 49.962

5.  Regulation of gene expression and cocaine reward by CREB and DeltaFosB.

Authors:  Colleen A McClung; Eric J Nestler
Journal:  Nat Neurosci       Date:  2003-10-19       Impact factor: 24.884

Review 6.  Glutamate systems in cocaine addiction.

Authors:  Peter W Kalivas
Journal:  Curr Opin Pharmacol       Date:  2004-02       Impact factor: 5.547

7.  Altered cortical synaptic morphology and impaired memory consolidation in forebrain- specific dominant-negative PAK transgenic mice.

Authors:  Mansuo L Hayashi; Se-Young Choi; B S Shankaranarayana Rao; Hae-Yoon Jung; Hey-Kyoung Lee; Dawei Zhang; Sumantra Chattarji; Alfredo Kirkwood; Susumu Tonegawa
Journal:  Neuron       Date:  2004-06-10       Impact factor: 17.173

8.  Pharmacological studies of the regulation of chronic FOS-related antigen induction by cocaine in the striatum and nucleus accumbens.

Authors:  H E Nye; B T Hope; M B Kelz; M Iadarola; E J Nestler
Journal:  J Pharmacol Exp Ther       Date:  1995-12       Impact factor: 4.030

9.  A gene expression atlas of the central nervous system based on bacterial artificial chromosomes.

Authors:  Shiaoching Gong; Chen Zheng; Martin L Doughty; Kasia Losos; Nicholas Didkovsky; Uta B Schambra; Norma J Nowak; Alexandra Joyner; Gabrielle Leblanc; Mary E Hatten; Nathaniel Heintz
Journal:  Nature       Date:  2003-10-30       Impact factor: 49.962

10.  D1 and D2 dopamine receptor function in the striatum: coactivation of D1- and D2-dopamine receptors on separate populations of neurons results in potentiated immediate early gene response in D1-containing neurons.

Authors:  C R Gerfen; K A Keefe; E B Gauda
Journal:  J Neurosci       Date:  1995-12       Impact factor: 6.167

View more
  184 in total

1.  A silent synapse-based mechanism for cocaine-induced locomotor sensitization.

Authors:  Travis E Brown; Brian R Lee; Ping Mu; Deveroux Ferguson; David Dietz; Yoshinori N Ohnishi; Ying Lin; Anna Suska; Masago Ishikawa; Yanhua H Huang; Haowei Shen; Peter W Kalivas; Barbara A Sorg; R Suzanne Zukin; Eric J Nestler; Yan Dong; Oliver M Schlüter
Journal:  J Neurosci       Date:  2011-06-01       Impact factor: 6.167

Review 2.  Novel dopamine D2 receptor signaling through proteins interacting with the third cytoplasmic loop.

Authors:  Kohji Fukunaga; Norifumi Shioda
Journal:  Mol Neurobiol       Date:  2011-12-20       Impact factor: 5.590

3.  N-methyl-D-aspartate (NMDA) receptor composition modulates dendritic spine morphology in striatal medium spiny neurons.

Authors:  Csaba Vastagh; Fabrizio Gardoni; Vincenza Bagetta; Jennifer Stanic; Elisa Zianni; Carmen Giampà; Barbara Picconi; Paolo Calabresi; Monica Di Luca
Journal:  J Biol Chem       Date:  2012-04-09       Impact factor: 5.157

4.  Cav1.2 L-type Ca²⁺ channels mediate cocaine-induced GluA1 trafficking in the nucleus accumbens, a long-term adaptation dependent on ventral tegmental area Ca(v)1.3 channels.

Authors:  Kathryn Schierberl; Jin Hao; Thomas F Tropea; Stephen Ra; Thomas P Giordano; Qinghao Xu; Sandra M Garraway; Franz Hofmann; Sven Moosmang; Joerg Striessnig; Charles E Inturrisi; Anjali M Rajadhyaksha
Journal:  J Neurosci       Date:  2011-09-21       Impact factor: 6.167

5.  Acute and chronic methylphenidate alters prefrontal cortex neuronal activity recorded from freely behaving rats.

Authors:  R Layla Salek; Catherine M Claussen; Adriana Pérez; Nachum Dafny
Journal:  Eur J Pharmacol       Date:  2012-01-25       Impact factor: 4.432

Review 6.  Integrated approaches to understanding antipsychotic drug action at GPCRs.

Authors:  Nikhil M Urs; Peter J Nicholls; Marc G Caron
Journal:  Curr Opin Cell Biol       Date:  2013-12-14       Impact factor: 8.382

7.  Cocaine-Dependent Acquisition of Locomotor Sensitization and Conditioned Place Preference Requires D1 Dopaminergic Signaling through a Cyclic AMP, NCS-Rapgef2, ERK, and Egr-1/Zif268 Pathway.

Authors:  Sunny Zhihong Jiang; Sean Sweat; Sam P Dahlke; Kathleen Loane; Gunner Drossel; Wenqin Xu; Hugo A Tejeda; Charles R Gerfen; Lee E Eiden
Journal:  J Neurosci       Date:  2020-12-02       Impact factor: 6.167

8.  Reduced ΔFosB expression in the rat nucleus accumbens has causal role in the neuropathic pain phenotype.

Authors:  Sarah L Pollema-Mays; Maria Virginia Centeno; Zheng Chang; A Vania Apkarian; Marco Martina
Journal:  Neurosci Lett       Date:  2018-11-29       Impact factor: 3.046

9.  Fragile X mental retardation protein regulates synaptic and behavioral plasticity to repeated cocaine administration.

Authors:  Laura N Smith; Jakub P Jedynak; Miles R Fontenot; Carly F Hale; Karen C Dietz; Makoto Taniguchi; Feba S Thomas; Benjamin C Zirlin; Shari G Birnbaum; Kimberly M Huber; Mark J Thomas; Christopher W Cowan
Journal:  Neuron       Date:  2014-05-07       Impact factor: 17.173

10.  Nuclear factor kappa B signaling regulates neuronal morphology and cocaine reward.

Authors:  Scott J Russo; Matthew B Wilkinson; Michelle S Mazei-Robison; David M Dietz; Ian Maze; Vaishnav Krishnan; William Renthal; Ami Graham; Shari G Birnbaum; Thomas A Green; Bruce Robison; Alan Lesselyong; Linda I Perrotti; Carlos A Bolaños; Arvind Kumar; Michael S Clark; John F Neumaier; Rachael L Neve; Asha L Bhakar; Philip A Barker; Eric J Nestler
Journal:  J Neurosci       Date:  2009-03-18       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.